Evidence map›Paper›PMID 34865624›Full record

Trial reportBMC medical research methodology2021

Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season.

Soledad Muñoz-Ramírez, Begoña Escribano-López, Vallivana Rodrigo-Casares, Carlos Vergara-Hernández, Desamparados Gil-Mary, Ignacio Sorribes-Monrabal, María Garcés-Sánchez, María-Jesús Muñoz-Del-Barrio, Ana-María Albors-Fernández, María-Isabel Úbeda-Sansano and 7 more

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC medical research methodology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Soledad Muñoz-RamírezFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain. soledad.munoz@fisabio.es.
Begoña Escribano-LópezFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Vallivana Rodrigo-CasaresFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Carlos Vergara-HernándezFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Desamparados Gil-MaryPrimary Health Center Malvarrosa, Valencia, Spain.
Ignacio Sorribes-MonrabalPrimary Health Center Serrería II, Valencia, Spain.
María Garcés-SánchezPrimary Health Center Nazaret, Valencia, Spain.
María-Jesús Muñoz-Del-BarrioPrimary Health Center Trafalgar, Valencia, Spain.
Ana-María Albors-FernándezPrimary Health Center Trafalgar, Valencia, Spain.
María-Isabel Úbeda-SansanoPrimary Health Center L'Eliana, Valencia, Spain.
María-Victoria Planelles-CantarinoPrimary Health Center Paiporta, Valencia, Spain.
Ester-María Largo-BlancoPrimary Health Center Paiporta, Valencia, Spain.
Eva Suárez-VicentPrimary Health Center Burriana II, Castellón, Spain.
Javier García-RubioFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Patricia Bruijning-VerhagenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Alejandro Orrico-SánchezFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Javier Díez-DomingoFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESMadrid Health Service · ESUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional clinical trials are conducted at investigator sites. Participants must visit healthcare facilities several times for the trial procedures. Decentralized clinical trials offer an interesting alternative. They use telemedicine and other technological solutions (apps, monitoring devices or web platforms) to decrease the number of visits to study sites, minimise the impact on daily routine, and decrease geographical barriers for participants. Not much information is available on the use of decentralization in randomized clinical trials with vaccines.

methodsA hybrid clinical trial may be assisted by parental recording of symptoms using electronic log diaries in combination with home collected nasal swabs. During two influenza seasons, children aged 12 to 35 months with a history of recurrent acute respiratory infections were recruited in 12 primary health centers of the Valencia Region in Spain. Parents completed a symptom diary through an ad hoc mobile app that subsequently assessed whether it was an acute respiratory infection and requested collection of a nasal swab. Feasibility was measured using the percentage of returned electronic diaries and the validity of nasal swabs collected during the influenza season. Respiratory viruses were detected by real-time PCR.

resultsNinety-nine toddlers were enrolled. Parents completed 10,476 electronic diaries out of the 10,804 requested (97%). The mobile app detected 188 potential acute respiratory infections (ARIs) and requested a nasal swab. In 173 (92%) ARI episodes a swab was taken. 165 (95.4%) of these swabs were collected at home and 144 (87.3%) of them were considered valid for laboratory testing. Overall, 152 (81%) of the ARIs detected in the study had its corresponding valid sample collected.

conclusionsHybrid procedures used in this clinical trial with the influenza vaccine in toddlers were considered adequate, as we diagnosed most of the ARI cases on time, and had a valid swab in 81% of the cases. Hybrid clinical trials improve participant adherence to the study procedures and could improve recruitment and quality of life of the participants and the research team by decreasing the number of visits to the investigator site. This report emphasises that the conduct of hybrid CTs is a valid alternative to traditional CTs with vaccines. This hybrid CT achieved high adherence of participant to the study procedures.

trial registration2019-001186-33 (EudraCT).

Indexed as

Influenza, HumanVirusesChild, PreschoolFeasibility StudiesHumansQuality of LifeSeasonsAcute respiratory infectionHybrid clinical trialsInfluenzaNasal swabParent Collection, electronic diaries, Mobile App Surveillance

Identifiers

PMID34865624
PMCPMC8645221
OpenAlexW4200202415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.